FORT COLLINS, Colo.--(BUSINESS WIRE)--VetDC, Inc., a veterinary cancer therapeutics company, today announced that the Company has received three major technical section complete letters for TanoveaTM (rabacfosadine) from the U.S. Food and Drug Administration’s Cen... Read more
